Human esterase D (carboxylesterase; carboxylic-ester hydrolase, EC 3.1.1.1), a genetic marker of retinoblastoma, was purified to biochemical homogeneity from erythrocytes. The purification scheme including carboxymethylcellulose, phenyl-Sepharose, chromatofocusing, and hydroxylapatite chromatographies resulted in a 10,000-fold purification of the enzyme with 15% recovery of total activity. The Km of esterase D was estimated to be 10 x 10-6 M using 4-methylumbelliferyl acetate as substrate. (8, 9) . In addition, the defective gene of Wilson disease was found to be linked to the esterase D gene (10). Thus, it is important to investigate the nature of the esterase D protein and its gene so as to understand these inherited disorders.
rification of the enzyme with 15% recovery of total activity. The Km of esterase D was estimated to be 10 x 10-6 M using 4-methylumbelliferyl acetate as substrate. The enzymatic activity was inhibited by p-chloromercuribenzoate and HgCI2, suggesting an important role of SH group(s) in enzyme function. Specific rabbit polyclonal and mouse monoclonal antibodies against esterase D were prepared and recognized either denatured or native human esterase D protein. Moreover, the polyconal antibodies immunoprecipitated a polypeptide with a molecular mass of about 33-34 kDa from various cell lines of different mammalian species, indicating that the esterase D protein is highly conserved. The highest levels of this enzyme were found in liver and kidney. Furthermore, the expression of esterase D was enhanced 3-fold in a promonocytic cell line treated with phenobarbital but not with phorbol myristate acetate, suggesting that esterase D may have a role in detoxification. The availability of the homogeneous protein and its specific antibodies allows for cloning of the esterase D gene and facilitates studies of retinoblastomas.
Human esterase D (carboxylesterase; carboxylic-ester hydrolase, EC 3.1.1.1) is one member of the nonspecific esterase family defined by their reaction with synthetic o-acyl ester substrates (1, 2) . This enzyme is distinguishable from other esterases by its electrophoretic mobility and its relative specificity for methylumbelliferyl esters as substrate (2) . The dimeric enzyme displays several phenotypes as a result of the expression of codominant autosomal alleles, primarily ESDI and ESD2. This polymorphic nature of esterase D provides a valuable genetic marker for studies in population genetics (2, 3) . Since the esterase D gene has been mapped to the chromosome 13q14.11 region where the putative retinoblastoma gene is also located (4) (5) (6) (7) , the polymorphic nature of the esterase D protein becomes a very useful genetic marker for the diagnosis ofhereditary retinoblastomas (8, 9) . In addition, the defective gene of Wilson disease was found to be linked to the esterase D gene (10) . Thus, it is important to investigate the nature of the esterase D protein and its gene so as to understand these inherited disorders.
Esterase D has been found in most tissues, but not much is known about its structure and function. A protocol for partial purification of this enzyme has been described (11) .
However, it remains difficult to obtain a sufficient amount of the homogeneous enzyme and to generate specific antibodies. In this communication, we describe the purification and characterization of this enzyme as well as the preparation of esterase D-specific polyclonal and monoclonal antibodies. Furthermore, we observed that this enzyme was mainly distributed in liver and kidney and could be induced by treatment with phenobarbital but not with phorbol ester.
MATERIALS AND METHODS
Esterase D Enzymatic Assays. (i) Quantitative assay. Esterase D activity was determined essentially as described (11) . The reaction was started by adding the enzyme into 1 ml of reaction buffer containing 50 mM potassium phosphate, 1 mM EDTA (pH 6.0), with 0.1 mM 4-methylumbelliferyl acetate as substrate. The 23 ,000 x g for 20 min and >95% of the hemoglobin was pelleted at this step. Buffers used in the subsequent steps all contained 1 mM EDTA, 0.1% 2-mercaptoethanol, and 0.05 mM phenylmethylsulfonyl fluoride (PhMeSO2F). The supernatant was then dialyzed overnight against several changes of 10 mM potassium phosphate buffer (pH 6.5).
Step 2. Carboxymethylcellulose C52 equilibrated with 10 mM potassium phosphate buffer (pH 6.5) was added to the Abbreviations: PhMeSO2F, phenylmethylsulfonyl fluoride; PMA, phorbol 12-myristate 13-acetate. tTo whom reprint requests should be addressed.
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Step 3. The protein precipitate was collected by centrifugation at 10,000 x g for 10 min and resuspended in and dialyzed against cold distilled water until just clarified. The protein sample was loaded onto a phenyl-Sepharose CL-4B column (5 x 27.5 cm) equilibrated with 50 mM Tris HCl buffer (pH 8.0) and 1 M ammonium sulfate. The column was washed extensively with the same buffer and then eluted with a decreasing gradient of ammonium sulfate (1.0-0 M) in 50 mM Tris HCl buffer (pH 8.0).
Step 4. The fractions with esterase activity from step 3 were concentrated by precipitation with 90o saturated ammonium sulfate, resuspended in 25 mM imidazole buffer (pH 7.4), and then dialyzed against the same buffer. The sample was loaded onto a chromatofocusing column (1.0 x 62 cm) of Pharmacia Polybuffer Exchanger 94 gel equilibrated with the same buffer and eluted with Polybuffer 74 (pH 4.0).
Step 5. The fractions with esterase D activity from the chromatofocusing column were pooled, concentrated with ammonium sulfate, dialyzed against 10 mM potassium phosphate buffer (pH 7.0), and loaded onto a column of hydroxylapatite (1 x 9.5 cm) equilibrated with the same buffer. The enzyme was then eluted with a gradient of ammonium sulfate (0-0.4 M) in the same buffer.
Purity of esterase D was monitored by NaDodSO4/polyacrylamide gel electrophoresis according to the procedures of Laemmli (14) . Proteins were stained with either Coomassie brilliant blue or silver. Protein was quantitated by the method of Lowry et al. (15) (16) .
(ii) Monoclonal antibodies. Antibody-producing hybridoma cell lines were generated as described (17) . Two hybridoma clones, TD-1 and TD-2, were isolated, both of which secreted high titers of antibodies against esterase D.
Immunoprecipitation. A standard protocol was followed as described (18) . RESULTS Purification of Esterase D. The purification scheme for esterase D from human erythrocytes is summarized in Table  1 . At each purification step esterase D was monitored by both agarose gel and NaDodSO4/polyacrylamide gel electrophoresis ( Fig. 1 ). Two steps, chloroform/butanol extraction and carboxymethyl-cellulose absorption, were necessary to remove all hemoglobin from the preparation. The (Fig. 1B) . Further purification by chromatofocusing chromatography separated the two activities from each other ( Fig. 2A) . The faster migrating form had a molecular mass of 30 kDa in NaDodSO4/PAGE. This previously unknown esterase was designated esterase X. The slower migrating form with a molecular mass of 34 kDa was esterase D, which was confirmed by electrophoresis in a starch gel (data not shown). To remove minor contaminating proteins in the esterase D pool, samples were further subjected to hydroxylapatite chromatography and eluted with a gradient of 0-0.4 M ammonium sulfate (Fig. 2B) . Esterase D eluted as a single peak and appeared to be homogeneous as judged by NaDodSO4/PAGE (Fig. 1, lanes 6 ). The Table 2 ). The enzymatic activity was inhibited completely by HgCl2 and pcmb at very low concentrations, suggesting that an SH group is essential to the enzymatic reaction. However, only at high concentrations could NaF and PhMeSO2F interfere with the enzyme activity. The antibodies we prepared did not affect the enzymatic activity even at high molar ratios of antibody to enzyme.
Polyclonal and Monoclonal Antibodies Against Esterase D. Rabbit anti-esterase D IgG was purified by esterase D affinity column chromatography or protein A-Sepharose column chromatography and used in subsequent experiments. The IgG recognized the denatured esterase D protein in immunoblotting (Fig. 3B) as well as the native protein following immunoprecipitation (Fig. 3D) . The immunocomplex of this IgG and the esterase D enzyme remains active in hydrolysis of 4-methylumbelliferyl acetate, which further demonstrates the specificity of the IgG (Fig. 3E) . Two hybridoma cell lines, TD-1 and TD-2, which produced high titers of antibodies against human esterase D protein, were also specifically recognized by denatured human esterase D protein in immunoblotting (Fig. 3C) .
Conservation of Esterase D. (1), detailed quantitative distribution has yet to be shown. We performed quantitative comparisons by two different measurements. First, aliquots of different rat tissue extracts with equal amounts of protein were assayed for esterase D enzymatic activity using 4-methylumbelliferyl acetate as substrate. As shown in Table 3 , liver and kidney had 10-to 6-fold higher enzymatic activity, respectively, than other Sam les of various tissues were homogenized on ice in 2 ml of 25 mM Tris-HCIl, pH 7.4/50 mM NaCl/0.2% Nonidet P-40/0.5% deoxycholate/1 mM PhMeSO2F. Extracts were clarified by centrifuging at 10,000 x g for 15 mi at 40C, and the supernatants were used for these experiments as described in the text. distributed with the highest level in liver and kidney suggest that it may have a role in detoxification. To test this possibility, phenobarbital was used to induce esterase D expression in a promonocytic cell line, U937, which was recently found to synthesize large quantities. df esterase D protein when compared with several other cell lines, including a human hepatoma, a retinoblastoma (Y79), a neuroblastoma (LA-N-5), and fibroblasts (unpublished observations). As shown in Fig. 4 A and B, 
